Cytodyn Inc (CYDY)

[CTMedic]

2020,

IMO CYDY stock is CURRENTLY over priced by $6.22

That is the beautiful part of free markets. We all get to place our bets with real money and reap the results.

It would appear that the markets (many thousands of investors) believe that Cytodyn is not over priced to the degree you believe.

The 50 day moving average is $5.52, ahead of the 200 day moving average of $3.91 and well ahead of the $2.28 share price when you joined the Cytodyn Investorshub community or $5.28 when I joined in August (what a roller coaster ride this has been!)

For what it is worth, that is $700,000,000 of Cytdoyn stock traded.

For every purchaser buying Cytodyn stock believing it will go higher is a seller believing it will go lower.

However, the sale price represents an equilibrium between these opposing views.

You may be right that Cytodyn will go to zero.

However, the better part of a BILLLION DOLLARS has been "bet" on the opposing view, just in the past 50 days.

Let's wait and see what happens with the CD12 trial results.

That should help determine which group, buyers or sellers (longs or shorts) has analyzed correctly the available information.

Patience.